Form 4: BioLargo President Converts Debt to Equity, Shares Locked Up

BioLargo's President and Director, Dennis P. Calvert, acquired 310,269 shares of common stock by converting salary and expense debt, with shares subject to a lock-up agreement tied to future company performance.

Summary

• Dennis P. Calvert, President and Director of BioLargo, Inc. (BLGO), acquired 310,269 shares of common stock on November 14, 2025.
• The shares were acquired at a price of $0.16 per share.
• This acquisition was a conversion of amounts owed by BioLargo to Mr. Calvert for salary and unreimbursed business expenses.
• Following this transaction, Mr. Calvert directly owns 10,393,403 shares, which includes 1,528,695 shares owned indirectly through a limited liability company.
• The newly issued shares are subject to a Lock-Up Agreement, restricting their sale until BioLargo reports gross revenue of at least $40 million, or its market capitalization exceeds $300 million, or a 'change in control' occurs.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The conversion of debt to equity improves the company's balance sheet and aligns management's interests with long-term growth through performance-based lock-up conditions. However, the future date of the transaction (11/14/2025) is unusual for a filing dated 11/17/2025, which could be a clerical error or indicate a future planned transaction, adding a slight element of uncertainty.

Positives

• The conversion of salary and expense debt into equity strengthens BioLargo's balance sheet by reducing liabilities.
• The lock-up agreement aligns management's interests with long-term shareholder value by tying share liquidity to significant company performance milestones (revenue and market capitalization).

Negatives

• The lock-up agreement restricts the immediate liquidity of the acquired shares for the reporting person, potentially limiting their personal financial flexibility.

Risks

• The value of the acquired shares remains subject to the company's ability to achieve significant future milestones, specifically gross revenue of $40 million or a market capitalization of $300 million, which are not guaranteed.
• The lock-up conditions introduce a dependency on future company performance for the reporting person's ability to monetize their equity, linking personal financial outcomes directly to corporate success.

Future Outlook

The lock-up agreement on the acquired shares indicates a forward-looking strategy tied to significant future performance milestones for BioLargo, specifically achieving $40 million in consolidated gross revenue or a market capitalization exceeding $300 million, or a change in control.

Management Comments

• Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares issued and the acquisition price per share).

Industry Context

This insider transaction reflects a common practice in early-stage or growth companies where executive compensation or outstanding debts are converted into equity to conserve cash and align management incentives with long-term company growth. The specific lock-up conditions are tailored to BioLargo's strategic goals, emphasizing revenue growth and market valuation, which are critical for companies in the biotechnology or clean technology sectors.

Comparison to Industry Standards

• Debt-to-equity conversions are a standard financial maneuver, particularly for companies seeking to improve cash flow or balance sheet health, similar to practices seen in startups and growth-stage companies across various industries.
• Lock-up agreements for insider shares are common, especially following IPOs or significant equity grants, to prevent immediate selling pressure. The specific performance-based triggers ($40M revenue, $300M market cap) are tailored to BioLargo's growth trajectory and are comparable to milestone-based vesting schedules seen in other emerging technology companies.

Corporate Governance

Related Party Transactions

• The acquisition of shares by Dennis P. Calvert, President and Director, in exchange for a reduction of salary and unreimbursed business expenses owed by the Issuer, constitutes a related party transaction.

Stakeholder Impact

• **Shareholders**: The conversion of debt to equity can be seen as positive, reducing liabilities and potentially improving financial stability. The lock-up agreement aligns management's incentives with long-term shareholder value creation.
• **Employees (specifically Dennis P. Calvert)**: Mr. Calvert's outstanding compensation is converted into equity, tying his personal wealth more directly to the company's future performance, but restricting immediate liquidity.
• **Creditors**: The reduction of outstanding debt (salary/expenses) improves the company's debt profile, potentially making it more attractive to future creditors.

Next Steps

• BioLargo aims to achieve consolidated gross revenue of at least $40 million for any reported period.
• BioLargo aims to increase its market capitalization to exceed $300 million.
• The lock-up agreement will remain in effect until one of the specified conditions (revenue, market cap, or change in control) is met.

Key Dates

Recommendation

The insider transaction, involving a debt-to-equity conversion with a performance-based lock-up, generally signals management's confidence and commitment to the company's long-term growth. It also improves the company's balance sheet by reducing liabilities. However, the transaction date being in the future (11/14/2025) for a current filing is unusual and warrants caution. While the alignment of interests is positive, the immediate impact on the stock price might be limited without further context on the company's current financial performance relative to the lock-up targets. Therefore, a 'hold' recommendation is appropriate, suggesting investors maintain their current position while monitoring future developments and clarification on the transaction date.

Keywords

BioLargo, BLGO, Dennis P. Calvert, insider transaction, Form 4, debt conversion, equity acquisition, lock-up agreement, corporate governance, management compensation